常染色体显性阿尔茨海默病临床试验的新型认知疾病进展模型
针对常染色体显性阿尔茨海默病,基于DIAN观察性研究开发了一种半参数认知疾病进展模型(DPM),该模型按疾病阶段对齐比较、采用类似Cox比例风险比的比例治疗效果,并利用不同随访时长的扩展数据;模拟显示其在假设性干预临床试验中较MMRM显著提高检验效能。
要点
- DPM按疾病阶段对齐受试者,而非仅以基线疾病阶段为协变量。
- DPM采用类似Cox比例风险比的比例治疗效果假设。
- DPM利用所有随访至末次访视的数据,不局限于固定随访时长。
核心结论
- 基于DIAN观察性研究开发的半参数认知DPM在假设性干预临床试验模拟中较MMRM产生显著的检验效能提升。
研究设计与样本
- 基于常染色体显性阿尔茨海默病Dominantly Inherited Alzheimer Network(DIAN)观察性研究数据开发半参数认知疾病进展模型(DPM),并通过模拟在假设性干预临床试验中与MMRM比较检验效能。
主要发现
- DPM具有三个新特征:按疾病阶段对齐和比较受试者、采用类似Cox比例风险比的比例治疗效果、纳入不同随访时长受试者的扩展随访数据直至末次访视。
- 模拟显示DPM在假设性干预临床试验中较MMRM产生显著的检验效能提升。
临床怎么用
- 在常染色体显性阿尔茨海默病临床试验中,可考虑采用DPM替代MMRM以利用不同随访时长数据并提高检验效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical trial outcomes for Alzheimer's disease are typically analyzed by using the mixed model for repeated measures (MMRM) or similar models that compare an efficacy scale change from baseline between treatment arms with or without participants' disease stage as a covariate. The MMRM focuses on a single-point fixed follow-up duration regardless of the exposure for each participant. In contrast to these typical models, we have developed a novel semiparametric cognitive disease progression model (DPM) for autosomal dominant Alzheimer's disease based on the Dominantly Inherited Alzheimer Network (DIAN) observational study. This model includes 3 novel features, in which the DPM (1) aligns and compares participants by disease stage, (2) uses a proportional treatment effect similar to the concept of the Cox proportional hazard ratio, and (3) incorporates extended follow-up data from participants with different follow-up durations using all data until last participant visit. We present the DPM model developed by using the DIAN observational study data and demonstrate through simulation that the cognitive DPM used in hypothetical intervention clinical trials produces substantial gains in power compared with the MMRM.
引用
- Wang G, Berry S, Xiong C, et al. A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease. Stat Med. 2018. PMID: 29761523. doi:10.1002/sim.7811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。